Literature DB >> 5483321

Effects of large doses of colistin sulphomethate sodium on renal function.

D J Price, D I Graham.   

Abstract

High doses of colistin were used in the treatment of severely ill patients with refractory klebsiella chest and urinary tract infections. At the same time renal function was monitored to determine possible nephrotoxicity. In all patients it produced acute renal failure and in some acute tubular necrosis. Though renal failure contributed to the final cause of death in some cases, in the majority death was due to the primary neurological illness.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5483321      PMCID: PMC1820005          DOI: 10.1136/bmj.4.5734.525

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  Colistin (coly-mycin) in resistant bacterial infections. A clinical appraisal.

Authors:  E M YOW; E TAN; L SHANE; S SCHONFELD; H ABU-NASSAR
Journal:  Arch Intern Med       Date:  1961-11

2.  Structural renal damage and its relatin to clinical features in acute oliguric renal failure.

Authors:  E S FINCKH; D JEREMY; H M WHYTE
Journal:  Q J Med       Date:  1962-10

3.  Nephropathy associated with methicillin therapy.

Authors:  G E Brauninger; J S Remington
Journal:  JAMA       Date:  1968-01-08       Impact factor: 56.272

4.  Nephropathy associated with penicillin and homologues.

Authors:  R W Schrier; R J Bulger; P P VanArsdel
Journal:  Ann Intern Med       Date:  1966-01       Impact factor: 25.391

5.  Renal function after acute tubular necrosis.

Authors:  J D Briggs; A C Kennedy; L N Young; R G Luke; M Gray
Journal:  Br Med J       Date:  1967-08-26

6.  Colistin in Pseudomonas pyocycanea infections and its effect on renal function.

Authors:  W Brumfitt; M Black; J D Williams
Journal:  Br J Urol       Date:  1966-10

7.  Acute renal failure associated with sodium colistimethate treatment.

Authors:  C M Elwood; G D Lucas; R C Muehrcke
Journal:  Arch Intern Med       Date:  1966-10

8.  The relative nephrotoxicities of polymyxin B sulfate, sodium sulfomethyl-polymyxin B, sodium sulfomethyl-colistin (colymycin), and neomycin sulfate.

Authors:  J Vinnicombe; T A Stamey
Journal:  Invest Urol       Date:  1969-03

9.  Comparative study of the effect of three antibiotics on renal function.

Authors:  A D Caldwell; A J Martin; D J Trigger
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

10.  Renin and acute renal failure: studies in man.

Authors:  J J Brown; R I Gleadle; D H Lawson; A F Lever; A L Linton; R F Macadam; E Prentice; M Tree; J I Robertson
Journal:  Br Med J       Date:  1970-01-31
View more
  19 in total

1.  Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.

Authors:  S P Conway; M N Pond; A Watson; C Etherington; H L Robey; M H Goldman
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

2.  The use of intravenous colistin among children in the United States: results from a multicenter, case series.

Authors:  Pranita D Tamma; Jason G Newland; Pia S Pannaraj; Talene A Metjian; Ritu Banerjee; Jeffrey S Gerber; Scott J Weissman; Susan E Beekmann; Philip M Polgreen; Adam L Hersh
Journal:  Pediatr Infect Dis J       Date:  2013-01       Impact factor: 2.129

3.  Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design.

Authors:  Kamilia Abdelraouf; Kirk H Braggs; Taijun Yin; Luan D Truong; Ming Hu; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

4.  Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells.

Authors:  Mohammad A K Azad; Ben A Finnin; Anima Poudyal; Kathryn Davis; Jinhua Li; Prue A Hill; Roger L Nation; Tony Velkov; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2013-06-24       Impact factor: 5.191

Review 5.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

6.  Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative Bacteria.

Authors:  Kade D Roberts; Mohammad A K Azad; Jiping Wang; Andrew S Horne; Philip E Thompson; Roger L Nation; Tony Velkov; Jian Li
Journal:  ACS Infect Dis       Date:  2015-09-04       Impact factor: 5.084

7.  Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria.

Authors:  John P Ouderkirk; Jill A Nord; Glenn S Turett; Jay Ward Kislak
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study.

Authors:  H Kallel; L Hergafi; M Bahloul; A Hakim; H Dammak; H Chelly; C Ben Hamida; A Chaari; N Rekik; M Bouaziz
Journal:  Intensive Care Med       Date:  2007-05-25       Impact factor: 17.440

9.  Klebsiella meningitis--report of nine cases.

Authors:  D J Price; J D Sleigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-12       Impact factor: 10.154

10.  Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock.

Authors:  Suresh Ramasubban; Ayanava Majumdar; Purnendu Sekhar Das
Journal:  Indian J Crit Care Med       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.